Psoriasis induced by cetuximab: A paradoxical adverse effect

Authors:

Abstract
Cetuximab, an epidermal growth factor receptor inhibitor, is a chemotherapeutical agent featuring well‐known adverse dermatological effects related to tumour‐response prognosis. In psoriasis, the epidermal growth factor receptor is overexpressed; hence, the expectation would be that an epidermal growth factor receptor inhibitor could improve psoriatic lesions. We report a case of psoriasis induced by cetuximab, which was a surprising adverse effect.

This publication has 11 references indexed in Scilit: